Incidence and case fatality of acute myocardial infarction in Norway 2013-2021.

Insidens og letalitet av akutt hjerteinfarkt i Norge 2013–21.

Journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
ISSN: 0807-7096
Titre abrégé: Tidsskr Nor Laegeforen
Pays: Norway
ID NLM: 0413423

Informations de publication

Date de publication:
15 Oct 2024
Historique:
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 15 10 2024
Statut: epublish

Résumé

Previous studies of the incidence and case fatality of acute myocardial infarction in Norway are based on administrative data that do not distinguish between myocardial infarction with ST segment elevation (STEMI) and without ST segment elevation (NSTEMI). The aim of this study was to investigate the incidence, case fatality and patient characteristics for different types of myocardial infarction in the period 2013-2021. The Norwegian Myocardial Infarction Registry, the Norwegian Patient Registry and the Norwegian Cause of Death Registry were linked in order to identify all patients with myocardial infarction. We calculated age-adjusted incidence and 30-day case fatality. Incidence of all types of myocardial infarction in total fell by 3.8 % per year on average (95 % CI 3.6-4.1). There was a reduction of 2.3 % (95 % CI 1.8-2.8) for STEMI, 3.1 % (95 % CI 2.8-3.4) for NSTEMI, and 6.5 % (95 % CI 5.9-7.1) for out-of-hospital deaths from myocardial infarction. Thirty-day case fatality for all types of myocardial infarction in total was 21.3 % in 2013 and 17.5 % in 2021. Case fatality for all infarctions fell by an average of 2.8 % per year (95 % CI 2.3-3.3), case fatality for NSTEMI fell by 4.4 % per year (95 % CI 3.3-5.5) per year, while case fatality for STEMI was unchanged. Incidence of all types of myocardial infarction declined in the period 2013-2021. Thirty-day case fatality remains high, despite a fall in case fatality for all myocardial infarctions in total and for NSTEMI. There was no change in case fatality for STEMI.

Sections du résumé

Background UNASSIGNED
Previous studies of the incidence and case fatality of acute myocardial infarction in Norway are based on administrative data that do not distinguish between myocardial infarction with ST segment elevation (STEMI) and without ST segment elevation (NSTEMI). The aim of this study was to investigate the incidence, case fatality and patient characteristics for different types of myocardial infarction in the period 2013-2021.
Material and method UNASSIGNED
The Norwegian Myocardial Infarction Registry, the Norwegian Patient Registry and the Norwegian Cause of Death Registry were linked in order to identify all patients with myocardial infarction. We calculated age-adjusted incidence and 30-day case fatality.
Results UNASSIGNED
Incidence of all types of myocardial infarction in total fell by 3.8 % per year on average (95 % CI 3.6-4.1). There was a reduction of 2.3 % (95 % CI 1.8-2.8) for STEMI, 3.1 % (95 % CI 2.8-3.4) for NSTEMI, and 6.5 % (95 % CI 5.9-7.1) for out-of-hospital deaths from myocardial infarction. Thirty-day case fatality for all types of myocardial infarction in total was 21.3 % in 2013 and 17.5 % in 2021. Case fatality for all infarctions fell by an average of 2.8 % per year (95 % CI 2.3-3.3), case fatality for NSTEMI fell by 4.4 % per year (95 % CI 3.3-5.5) per year, while case fatality for STEMI was unchanged.
Interpretation UNASSIGNED
Incidence of all types of myocardial infarction declined in the period 2013-2021. Thirty-day case fatality remains high, despite a fall in case fatality for all myocardial infarctions in total and for NSTEMI. There was no change in case fatality for STEMI.

Identifiants

pubmed: 39404247
pii: 24-0237
doi: 10.4045/tidsskr.24.0237
doi:

Types de publication

Journal Article

Langues

eng nor

Sous-ensembles de citation

IM

Auteurs

Kaare Harald Bønaa (KH)

Norsk hjerteinfarktregister, St. Olavs hospital, og, Klinikk for hjertemedisin, St. Olavs hospital, og, Institutt for sirkulasjon og bildediagnostikk, NTNU.

Kari Krizak Halle (KK)

Norsk hjerteinfarktregister, St. Olavs hospital.

Ragna Elise Støre Govatsmark (RES)

Norsk hjerteinfarktregister, St. Olavs hospital.

Veronica Bendiktsen Berge (VB)

Norsk hjerteinfarktregister, St. Olavs hospital.

Ida Almenning Kiel (IA)

Norsk hjerteinfarktregister, St. Olavs hospital.

Gerhard Sulo (G)

Institutt for global helse og samfunnsmedisin, Universitetet i Bergen.

Rune Kvåle (R)

Seksjon for epidemiologi og forebygging, Kreftregisteret, Folkehelseinstituttet.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH